SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Earnings yield ratio
5Y CAGR
+32.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 18.38% | +118.9% |
| 2024 | -97.16% | +12.5% |
| 2023 | -111.08% | -52.2% |
| 2022 | -73.00% | -1345.5% |
| 2021 | -5.05% | -210.8% |
| 2020 | 4.56% | +323.9% |
| 2019 | -2.04% | - |